$VTGN
VistaGen Therapeutics Inc
PRICE
$3.6 ▼-4.255%
Delayed Price
VOLUME
197,080
DAY RANGE
-
52 WEEK
1.62 - 24.71
Key Metrics
Market Cap
101.61 M
Beta
4.67
Avg. Volume
610.44 K
Shares Outstanding
27.02 M
Yield
0%
Public Float
0
Next Earnings Date
2024-02-06
Next Dividend Date
Company Information
we have developed a versatile stem cell technology platform based on the controlled differentiation of human pluripotent stem cells into mature, non-transformed, human cells which can be used to create novel bioassay systems for predictive toxicology, drug metabolism screening, drug discovery, drug rescue and cell therapy. we believe our stem cell technology platform, human clinical trials in a test tube™, can provide clinically relevant predictions of potential toxicity and metabolism issues of promising new drug candidates long before they are ever tested in humans.
Website: vistagen.com
HQ: ,
Related News